B. Feagan, M. Vreeland, L. Larson, and M. Bala, Annual cost of care for Crohn's disease: a payor perspective, The American Journal of Gastroenterology, vol.117, issue.8, p.195560, 2000.
DOI : 10.1111/j.1572-0241.2000.01779.x

J. Burisch, H. Vardi, N. Pedersen, M. Brinar, S. Cukovic-cavka et al., Costs and Resource Utilization for Diagnosis and Treatment During the Initial Year in a European Inflammatory Bowel Disease Inception Cohort, Inflammatory Bowel Diseases, vol.21, issue.1, p.12131, 2015.
DOI : 10.1097/MIB.0000000000000250

I. Vind, L. Riis, J. T. Knudsen, E. Pedersen, N. Elkjaer et al., Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003.

G. Rubin, A. Hungin, P. Kelly, and J. Ling, Inflammatory bowel disease: epidemiology and management in an English general practice population, Alimentary Pharmacology and Therapeutics, vol.75, issue.12, p.15539, 2000.
DOI : 10.1136/gut.46.3.336

C. Loftus, E. Loftus, W. Harmsen, A. Zinsmeister, W. Tremaine et al., Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Inflamm Bowel Dis, vol.13, issue.3, p.25461, 1940.

C. Bernstein, A. Wajda, L. Svenson, A. Mackenzie, M. Koehoorn et al., The Epidemiology of Inflammatory Bowel Disease in Canada: A Population-Based Study, The American Journal of Gastroenterology, vol.42, issue.7
DOI : 10.1007/s004310050066

J. Cosnes, C. Gower-rousseau, P. Seksik, and A. Cortot, Epidemiology and Natural History of Inflammatory Bowel Diseases, Gastroenterology, vol.140, issue.6, p.178594, 2011.
DOI : 10.1053/j.gastro.2011.01.055

URL : https://hal.archives-ouvertes.fr/hal-00631553

J. Burisch and P. Munkholm, The epidemiology of inflammatory bowel disease, Scand J Gastroenterol, vol.50, issue.8, p.94251, 2015.

C. Ott, F. Obermeier, S. Thieler, D. Kemptner, A. Bauer et al., The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study, European Journal of Gastroenterology & Hepatology, vol.20, issue.9, p.91723, 2008.
DOI : 10.1097/MEG.0b013e3282f97b33

J. Colombel, G. Vernier-massouille, A. Cortot, C. Gower-rousseau, and J. Salomez, Epidemiology and risk factors of inflammatory bowel diseases, Bull Académie Natl Medecine, vol.191, issue.6, p.110518, 2007.

V. Chouraki, G. Savoye, L. Dauchet, G. Vernier-massouille, J. Dupas et al., The changing pattern of Crohn's disease incidence in northern France: a continuing increase in the 10-to 19-year-old age bracket, Aliment Pharmacol Ther, vol.33, issue.10, p.113342, 1988.

V. Nerich, E. Monnet, E. A. Louafi, S. Ramée, C. Rican et al., Geographical variations of inflammatory bowel disease in France: A study based on national health insurance data, Inflammatory Bowel Diseases, vol.12, issue.3, p.21826, 2006.
DOI : 10.1097/01.MIB.0000206540.38834.8c

URL : https://hal.archives-ouvertes.fr/hal-00466309

C. Gower-rousseau, F. Vasseur, M. Fumery, G. Savoye, J. Salleron et al., Epidemiology of inflammatory bowel diseases: New insights from a French population-based registry (EPIMAD), Digestive and Liver Disease, vol.45, issue.2, p.8994, 2013.
DOI : 10.1016/j.dld.2012.09.005

URL : https://hal.archives-ouvertes.fr/tel-00820631

S. Shivananda, J. Lennard-jones, R. Logan, N. Fear, A. Price et al., Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD)., Gut, vol.39, issue.5, p.6907, 1996.
DOI : 10.1136/gut.39.5.690

O. Abramson, M. Durant, W. Mow, A. Finley, P. Kodali et al., Incidence, prevalence, and time trends of pediatric inflammatory bowel disease in Northern California, J Pediatr, vol.157, issue.2, p.2339, 1996.

C. Charpentier, J. Salleron, G. Savoye, M. Fumery, V. Merle et al., Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study, Gut, vol.139, issue.Suppl 2, p.42332, 2014.
DOI : 10.1136/gutjnl-2012-303864

F. Molinié, C. Gower-rousseau, T. Yzet, V. Merle, B. Grandbastien et al., Opposite evolution in incidence of Crohn's disease and ulcerative colitis in Northern France, Gut, vol.53, issue.6, p.8438, 1988.

R. Gearry, A. Richardson, C. Frampton, J. Collett, M. Burt et al., High incidence of Crohn's disease in Canterbury, New Zealand: results of an epidemiologic study, Inflamm Bowel Dis, vol.12, issue.10, p.93643, 2006.

B. Khor, A. Gardet, and R. Xavier, Genetics and pathogenesis of inflammatory bowel disease, Nature, vol.105, issue.7351, p.30717, 2011.
DOI : 10.1038/nature10209

I. Zvidi, R. Hazazi, S. Birkenfeld, and Y. Niv, The Prevalence of Crohn???s Disease in Israel: A 20-Year Survey, Digestive Diseases and Sciences, vol.14, issue.Suppl 170, p.84852, 2009.
DOI : 10.1007/s10620-008-0429-1

I. Zvidi, G. Fraser, Y. Niv, and S. Birkenfeld, The prevalence of inflammatory bowel disease in an Israeli Arab population, Journal of Crohn's and Colitis, vol.7, issue.5, p.15963, 2013.
DOI : 10.1016/j.crohns.2012.07.026

J. Cho and C. Weaver, The genetics of inflammatory bowel disease, Gastroenterology, vol.133, issue.4, p.132739, 2007.

C. Abraham and J. Cho, Functional consequences of NOD2 (CARD15) mutations, Inflammatory Bowel Diseases, vol.12, issue.7, p.64150, 2006.
DOI : 10.1097/01.MIB.0000225332.83861.5f

C. Abraham and J. Cho, Inflammatory Bowel Disease, New England Journal of Medicine, vol.361, issue.21, pp.2066-78, 2009.
DOI : 10.1056/NEJMra0804647

K. Goh and S. Xiao, Inflammatory bowel disease: A survey of the epidemiology in Asia, Journal of Digestive Diseases, vol.53, issue.Suppl 8, p.16, 2009.
DOI : 10.1111/j.1751-2980.2008.00355.x

B. Calkins, A meta-analysis of the role of smoking in inflammatory bowel disease, Digestive Diseases and Sciences, vol.284, issue.12, p.184154, 1989.
DOI : 10.1007/BF01536701

A. Ananthakrishnan, Environmental Risk Factors for Inflammatory Bowel Diseases: A Review, Digestive Diseases and Sciences, vol.141, issue.Suppl 2, p.2908, 2015.
DOI : 10.1007/s10620-014-3350-9

H. Sokol, B. Pigneur, L. Watterlot, O. Lakhdari, L. Bermúdez-humarán et al., Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients, Proceedings of the National Academy of Sciences, vol.105, issue.43, p.167316, 2008.
DOI : 10.1073/pnas.0804812105

URL : https://hal.archives-ouvertes.fr/hal-00652961

C. Manichanh, L. Rigottier-gois, E. Bonnaud, K. Gloux, E. Pelletier et al., Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach, Gut, vol.55, issue.2, p.20511, 2006.
DOI : 10.1136/gut.2005.073817

C. Neut, P. Bulois, P. Desreumaux, J. Membré, E. Lederman et al., Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease, The American Journal of Gastroenterology, vol.119, issue.4, p.93946, 2002.
DOI : 10.1023/A:1026632704628

R. Duchmann, I. Kaiser, E. Hermann, W. Mayet, K. Ewe et al., Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD), Clinical & Experimental Immunology, vol.19, issue.3, p.44855, 1995.
DOI : 10.1111/j.1365-2249.1995.tb03836.x

T. Kobayashi, S. Okamoto, T. Hisamatsu, N. Kamada, H. Chinen et al., IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease, Gut, vol.57, issue.12, p.16829, 2008.
DOI : 10.1136/gut.2007.135053

L. Peyrin-biroulet, E. Loftus, J. Colombel, and W. Sandborn, Long-term complications, extraintestinal manifestations, and mortality in adult Crohn's disease in population-based cohorts, Inflamm Bowel Dis, vol.17, issue.1, p.4718, 2011.

B. Pariente, J. Cosnes, S. Danese, W. Sandborn, M. Lewin et al., Development of the Crohn's disease digestive damage score, the Lémann score, Inflamm Bowel Dis, vol.17, issue.6, p.141522, 2011.

G. Olaison, K. Smedh, and R. Sjödahl, Natural course of Crohn's disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms., Gut, vol.33, issue.3, p.3315, 1992.
DOI : 10.1136/gut.33.3.331

J. Satsangi, M. Silverberg, S. Vermeire, and J. Colombel, The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications, Gut, vol.55, issue.6, p.74953, 2006.
DOI : 10.1136/gut.2005.082909

J. Gollop, S. Phillips, L. Melton, and A. Zinsmeister, Epidemiologic aspects of Crohn's disease: a population based study in Olmsted County, Minnesota, 1943-1982., Gut, vol.29, issue.1, p.4956, 1988.
DOI : 10.1136/gut.29.1.49

M. Henriksen, J. Jahnsen, I. Lygren, E. Aadland, T. Schulz et al., Clinical course in Crohn's disease: Results of a five-year population-based follow-up study (the IBSEN study), Scandinavian Journal of Gastroenterology, vol.4, issue.4, p.60210, 2007.
DOI : 10.1111/j.1572-0241.2002.05475.x

I. Solberg, M. Vatn, O. Høie, N. Stray, J. Sauar et al., Clinical Course in Crohn???s Disease: Results of a Norwegian Population-Based Ten-Year Follow-Up Study, Clinical Gastroenterology and Hepatology, vol.5, issue.12, p.14308, 2007.
DOI : 10.1016/j.cgh.2007.09.002

F. Wolters, M. Russel, J. Sijbrandij, T. Ambergen, S. Odes et al., Phenotype at diagnosis predicts recurrence rates in Crohn's disease, Gut, vol.55, issue.8, p.112430, 2006.
DOI : 10.1136/gut.2005.084061

E. Louis, A. Collard, A. Oger, E. Degroote, F. Yafi et al., Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease, Gut, vol.49, issue.6, p.77782, 2001.
DOI : 10.1136/gut.49.6.777

L. Peyrin-biroulet, W. Harmsen, W. Tremaine, A. Zinsmeister, W. Sandborn et al., Surgery in a population-based cohort of Crohn's disease from Olmsted County, Am J Gastroenterol, vol.107, issue.11, p.1693701, 1970.

K. Thia, W. Sandborn, W. Harmsen, A. Zinsmeister, and E. Loftus, Risk Factors Associated With Progression to Intestinal Complications of Crohn's Disease in a Population-Based Cohort, Gastroenterology, vol.139, issue.4, p.114755, 2010.
DOI : 10.1053/j.gastro.2010.06.070

J. Cosnes, Crohn's disease phenotype, prognosis, and long-term complications: what to expect? Acta Gastro-Enterol Belg, p.3037, 2008.

L. Beaugerie, P. Seksik, I. Nion-larmurier, J. Gendre, and J. Cosnes, Predictors of Crohn???s Disease, Gastroenterology, vol.130, issue.3, p.6506, 2006.
DOI : 10.1053/j.gastro.2005.12.019

D. Schwartz, E. Loftus, W. Tremaine, R. Panaccione, W. Harmsen et al., The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota, Gastroenterology, vol.122, issue.4, p.87580, 2002.
DOI : 10.1053/gast.2002.32362

L. Peyrin-biroulet, E. Loftus, J. Colombel, and W. Sandborn, The Natural History of Adult Crohn's Disease in Population-Based Cohorts, The American Journal of Gastroenterology, vol.132, issue.2, p.28997, 2010.
DOI : 10.1053/j.gastro.2008.09.053

C. Bernstein, J. Blanchard, P. Rawsthorne, and N. Yu, The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study, The American Journal of Gastroenterology, vol.11, issue.3, p.111622, 2001.
DOI : 10.1016/0049-0172(91)90011-N

S. Vavricka, L. Brun, P. Ballabeni, V. Pittet, P. Vavricka et al., Frequency and Risk Factors for Extraintestinal Manifestations in the Swiss Inflammatory Bowel Disease Cohort, The American Journal of Gastroenterology, vol.107, issue.1, p.1109, 2011.
DOI : 10.1016/j.crohns.2007.10.006

A. Akobeng and E. Gardener, Oral 5-aminosalicylic acid for maintenance of medicallyinduced remission in Crohn's Disease, Cochrane Database Syst Rev, issue.1, p.3715, 2005.

M. Gordon, K. Naidoo, A. Thomas, and A. Akobeng, Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease, Cochrane Database Syst Rev, issue.1, p.8414, 2011.

P. Munkholm, E. Langholz, M. Davidsen, and V. Binder, Frequency of glucocorticoid resistance and dependency in Crohn's disease., Gut, vol.35, issue.3, p.3602, 1994.
DOI : 10.1136/gut.35.3.360

W. Faubion, E. Loftus, W. Harmsen, A. Zinsmeister, and W. Sandborn, The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study, Gastroenterology, vol.121, issue.2, p.25560, 2001.
DOI : 10.1053/gast.2001.26279

G. Greenberg, B. Feagan, F. Martin, L. Sutherland, A. Thomson et al., Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group, N Engl J Med, vol.331, issue.13, p.83641, 1994.

E. Prefontaine, J. Macdonald, and L. Sutherland, Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease, Cochrane Database Syst Rev, issue.4, p.545, 2009.

Y. Bouhnik, M. Lémann, J. Mary, G. Scemama, R. Taï et al., Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine, The Lancet, vol.347, issue.8996, p.2159, 1996.
DOI : 10.1016/S0140-6736(96)90402-X

D. Pearson, G. May, G. Fick, and L. Sutherland, Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis, Ann Intern Med, vol.123, issue.2, p.13242, 1995.

W. Reinisch, S. Angelberger, W. Petritsch, O. Shonova, M. Lukas et al., Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial, Gut, vol.59, issue.6, p.7529, 2010.
DOI : 10.1136/gut.2009.194159

L. Beaugerie, N. Brousse, A. Bouvier, J. Colombel, M. Lémann et al., Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study, The Lancet, vol.374, issue.9701, p.161725, 2009.
DOI : 10.1016/S0140-6736(09)61302-7

URL : https://hal.archives-ouvertes.fr/hal-00466312

M. Long, C. Martin, C. Pipkin, H. Herfarth, R. Sandler et al., Risk of Melanoma and Nonmelanoma Skin Cancer Among Patients With Inflammatory Bowel Disease, Gastroenterology, vol.143, issue.2, p.3909, 2012.
DOI : 10.1053/j.gastro.2012.05.004

D. Kotlyar, M. Osterman, R. Diamond, D. Porter, W. Blonski et al., A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients With Inflammatory Bowel Disease, Clinical Gastroenterology and Hepatology, vol.9, issue.1, p.3641, 2011.
DOI : 10.1016/j.cgh.2010.09.016

A. Thai and T. Prindiville, Hepatosplenic T-cell lymphoma and inflammatory bowel disease, Journal of Crohn's and Colitis, vol.4, issue.5, p.51122, 2010.
DOI : 10.1016/j.crohns.2010.05.006

D. Kotlyar, J. Lewis, L. Beaugerie, A. Tierney, C. Brensinger et al., Risk of Lymphoma in Patients With Inflammatory Bowel Disease Treated With Azathioprine and 6-Mercaptopurine: A Meta-analysis, Clinical Gastroenterology and Hepatology, vol.13, issue.5, p.84758, 2015.
DOI : 10.1016/j.cgh.2014.05.015

URL : https://hal.archives-ouvertes.fr/hal-00998407

S. Targan, S. Hanauer, S. Van-deventer, L. Mayer, D. Present et al., A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor ?? for Crohn's Disease, New England Journal of Medicine, vol.337, issue.15, pp.1029-1064, 1997.
DOI : 10.1056/NEJM199710093371502

S. Hanauer, B. Feagan, G. Lichtenstein, L. Mayer, S. Schreiber et al., Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial, The Lancet, vol.359, issue.9317, p.15419, 2002.
DOI : 10.1016/S0140-6736(02)08512-4

J. Colombel, W. Sandborn, P. Rutgeerts, R. Enns, S. Hanauer et al., Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn???s Disease: The CHARM Trial, Gastroenterology, vol.132, issue.1, p.5265, 2007.
DOI : 10.1053/j.gastro.2006.11.041

D. Present, P. Rutgeerts, S. Targan, S. Hanauer, L. Mayer et al., Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease, New England Journal of Medicine, vol.340, issue.18, p.1398405, 1999.
DOI : 10.1056/NEJM199905063401804

B. Sands, F. Anderson, C. Bernstein, W. Chey, B. Feagan et al., Infliximab Maintenance Therapy for Fistulizing Crohn's Disease, New England Journal of Medicine, vol.350, issue.9, p.87685, 2004.
DOI : 10.1056/NEJMoa030815

G. Lichtenstein, B. Feagan, R. Cohen, B. Salzberg, R. Diamond et al., Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT??? Registry, The American Journal of Gastroenterology, vol.31, issue.9, p.140922, 2012.
DOI : 10.3899/jrheum.100347

L. Peyrin-biroulet, P. Deltenre, N. De-suray, J. Branche, W. Sandborn et al., Efficacy and Safety of Tumor Necrosis Factor Antagonists in Crohn's Disease: Meta-Analysis of Placebo-Controlled Trials, Clinical Gastroenterology and Hepatology, vol.6, issue.6, p.64453, 2008.
DOI : 10.1016/j.cgh.2008.03.014

L. Biancone, A. Orlando, A. Kohn, E. Colombo, R. Sostegni et al., Infliximab and newly diagnosed neoplasia in Crohn's disease: a multicentre matched pair study, Gut, vol.55, issue.2, p.22833, 2006.
DOI : 10.1136/gut.2005.075937

K. Bendtzen, M. Ainsworth, C. Steenholdt, O. Thomsen, and J. Brynskov, Individual medicine in inflammatory bowel disease: Monitoring bioavailability, pharmacokinetics and immunogenicity of anti-tumour necrosis factor-alpha antibodies, Scandinavian Journal of Gastroenterology, vol.30, issue.5, p.77481, 2009.
DOI : 10.1053/j.gastro.2006.11.041

A. Moss, V. Brinks, and J. Carpenter, Review article: immunogenicity of anti-TNF biologics in IBD - the role of patient, product and prescriber factors, Alimentary Pharmacology & Therapeutics, vol.28, issue.(Suppl 1), p.118897, 2013.
DOI : 10.1111/apt.12507

X. Roblin, M. Rinaudo, M. Sparrow, A. Moreau, J. Phelip et al., Pharmacokinetics in IBD: Ready for Prime Time?, Current Drug Targets, vol.15, issue.11, pp.1049-55, 2014.
DOI : 10.2174/1389450115666140829153509

S. Vermeire, M. Noman, G. Van-assche, F. Baert, D. Haens et al., Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease, Gut, vol.56, issue.9, p.122631, 2007.
DOI : 10.1136/gut.2006.099978

J. Colombel, W. Sandborn, W. Reinisch, G. Mantzaris, A. Kornbluth et al., Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease, New England Journal of Medicine, vol.362, issue.15, p.138395, 2010.
DOI : 10.1056/NEJMoa0904492

G. Bouguen and L. Peyrin-biroulet, Surgery for adult Crohn's disease: what is the actual risk?, Gut, vol.60, issue.9, p.117881, 2011.
DOI : 10.1136/gut.2010.234617

G. Hellers, Crohn's disease in Stockholm county 1955-1974. A study of epidemiology, results of surgical treatment and long-term prognosis, Acta Chir Scand, vol.490, p.184, 1979.

J. Cosnes, F. Carbonnel, F. Carrat, L. Beaugerie, S. Cattan et al., Effects of current and former cigarette smoking on the clinical course of Crohn's disease, Alimentary Pharmacology and Therapeutics, vol.30, issue.11, p.140311, 1999.
DOI : 10.1001/archinte.157.12.1371

P. Lakatos, F. Szalay, Z. Tulassay, T. Molnar, A. Kovacs et al., Clinical presentation of Crohn's disease: association between familial disease, smoking, disease phenotype, extraintestinal manifestations and need for surgery, Zeitschrift f??r Gastroenterologie, vol.43, issue.05, p.81722, 2005.
DOI : 10.1055/s-2005-869716

O. Bernell, A. Lapidus, and G. Hellers, Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn's disease, British Journal of Surgery, vol.84, issue.12, p.1697701, 2000.
DOI : 10.1046/j.1365-2168.2000.01589.x

M. Agrez, R. Valente, W. Pierce, L. Melton, J. Van-heerden et al., Surgical history of Crohn's disease in a well-defined population, Mayo Clin Proc, vol.57, issue.12, p.74752, 1982.

M. Bewtra, C. Su, and J. Lewis, Trends in Hospitalization Rates for Inflammatory Bowel Disease in the United States, Clinical Gastroenterology and Hepatology, vol.5, issue.5, p.597601, 2007.
DOI : 10.1016/j.cgh.2007.01.015

G. Nguyen, A. Tuskey, T. Dassopoulos, M. Harris, and S. Brant, Rising hospitalization rates for inflammatory bowel disease in the United States between, Inflamm Bowel Dis, vol.13, issue.12, p.152935, 1998.

C. Kerner, K. Carey, A. Mills, W. Yang, M. Synnestvedt et al., Use of Abdominopelvic Computed Tomography in Emergency Departments and Rates of Urgent Diagnoses in Crohn's Disease, Clinical Gastroenterology and Hepatology, vol.10, issue.1, p.527, 2012.
DOI : 10.1016/j.cgh.2011.09.005

A. Ananthakrishnan, E. Mcginley, K. Saeian, and D. Binion, Trends in ambulatory and emergency room visits for inflammatory bowel diseases in the United States, pp.1994-2005

K. Hunt, E. Weber, J. Showstack, D. Colby, and M. Callaham, Characteristics of Frequent Users of Emergency Departments, Annals of Emergency Medicine, vol.48, issue.1, p.18, 2006.
DOI : 10.1016/j.annemergmed.2005.12.030

D. Vinton, R. Capp, S. Rooks, J. Abbott, and A. Ginde, Frequent users of US emergency departments: characteristics and opportunities for intervention, Emergency Medicine Journal, vol.92, issue.(6), 2014.
DOI : 10.1136/emermed-2013-202407

B. Sun, H. Burstin, and T. Brennan, Predictors and Outcomes of Frequent Emergency Department Users, Academic Emergency Medicine, vol.174, issue.4, p.3208, 2003.
DOI : 10.1016/S0735-6757(98)90166-8

P. Panopalis, J. Gillis, J. Yazdany, L. Trupin, A. Hersh et al., Frequent use of the emergency department among persons with systemic lupus erythematosus, Arthritis Care & Research, vol.57, issue.3, p.4018, 2010.
DOI : 10.1002/acr.20107

A. Noble, L. Goldstein, P. Seed, E. Glucksman, and L. Ridsdale, Characteristics of people with epilepsy who attend emergency departments: Prospective study of metropolitan hospital attendees, Epilepsia, vol.26, issue.2, p.18208, 2012.
DOI : 10.1111/j.1528-1167.2012.03586.x

K. Hasegawa, A. Sullivan, T. Hirashima, E. Gaeta, T. Fee et al., A Multicenter Observational Study of US Adults with Acute Asthma: Who Are the Frequent Users of the Emergency Department?, The Journal of Allergy and Clinical Immunology: In Practice, vol.2, issue.6, p.73340, 2014.
DOI : 10.1016/j.jaip.2014.06.012

E. Israeli, S. Ying, B. Henderson, J. Mottola, T. Strome et al., The impact of abdominal computed tomography in a tertiary referral centre emergency department on the management of patients with inflammatory bowel disease, Alimentary Pharmacology & Therapeutics, vol.35, issue.5, p.51321, 2013.
DOI : 10.1111/apt.12410

S. Govani, A. Guentner, A. Waljee, and P. Higgins, Risk Stratification of Emergency Department Patients With Crohn's Disease Could Reduce Computed Tomography Use by Nearly Half, Clinical Gastroenterology and Hepatology, vol.12, issue.10, p.17027, 2014.
DOI : 10.1016/j.cgh.2014.02.036

A. Yarur, A. Mandalia, R. Dauer, F. Czul, A. Deshpande et al., Predictive factors for clinically actionable computed tomography findings in inflammatory bowel disease patients seen in the emergency department with acute gastrointestinal symptoms, Journal of Crohn's and Colitis, vol.8, issue.6, p.50412, 2014.
DOI : 10.1016/j.crohns.2013.11.003

M. Kappelman, S. Rifas-shiman, C. Porter, D. Ollendorf, R. Sandler et al., Direct Health Care Costs of Crohn's Disease and Ulcerative Colitis in US Children and Adults, Gastroenterology, vol.135, issue.6, p.190713, 2008.
DOI : 10.1053/j.gastro.2008.09.012

C. Bernstein and A. Nabalamba, Hospitalization, Surgery, and Readmission Rates of IBD in Canada: A Population-Based Study, The American Journal of Gastroenterology, vol.10, issue.1, p.1108, 2006.
DOI : 10.1016/S0016-5085(99)70549-4

S. Ingle, E. Loftus, and W. Harmsen, Hospitalization rates for Crohn's disease patients in Olmsted county, Minnesota, in the pre-biologic area, Am J Gastroenterol, vol.102, p.487, 2007.

E. Hoffenberg, K. Park, D. Dykes, J. Fridge, M. Kappelman et al., Appropriateness of Emergency Department Use in Pediatric Inflammatory Bowel Disease, Journal of Pediatric Gastroenterology and Nutrition, vol.59, issue.3, p.3246, 2014.
DOI : 10.1097/MPG.0000000000000457

D. Jewell, J. Satsangi, A. Lobo, C. Probert, A. Forbes et al., Infliximab use in Crohn's disease: impact on health care resources in the UK, Eur J Gastroenterol Hepatol, vol.17, issue.10, p.104752, 2005.

C. Saro, C. Da-la-coba, M. Casado, J. Morales, and B. Otero, Resource use in patients with Crohn???s disease treated with infliximab, Alimentary Pharmacology & Therapeutics, vol.125, issue.Suppl. 6, p.131323, 2007.
DOI : 10.1111/j.1365-2036.2007.03507.x

J. Rubenstein, R. Chong, and R. Cohen, Infliximab Decreases Resource Use Among Patients With Crohn's Disease, Journal of Clinical Gastroenterology, vol.35, issue.2, p.1516, 2002.
DOI : 10.1097/00004836-200208000-00007

C. Saro, D. Ceballos, F. Muñoz, C. De-la-coba, M. Aguilar et al., Resources Utilization and Costs the Year Before and After Starting Treatment with Adalimumab in Crohn's Disease Patients, Inflamm Bowel Dis, vol.21, issue.7, p.163140, 2015.

D. Loomes, C. Teshima, P. Jacobs, and R. Fedorak, Health Care Resource Use and Costs for Crohn???s Disease before and after Infliximab Therapy, Canadian Journal of Gastroenterology, vol.25, issue.9, p.497502, 2011.
DOI : 10.1155/2011/157604

G. Nguyen, N. Bollegala, and C. Chong, Factors Associated With Readmissions and Outcomes of Patients Hospitalized for Inflammatory Bowel Disease, Clinical Gastroenterology and Hepatology, vol.12, issue.11, p.1897904, 2014.
DOI : 10.1016/j.cgh.2014.02.042

G. Nguyen, L. Sheng, and E. Benchimol, Health Care Utilization in Elderly Onset Inflammatory Bowel Disease, Inflammatory Bowel Diseases, vol.21, issue.4, p.77782, 2015.
DOI : 10.1097/MIB.0000000000000306

D. Larson, L. Johnson, B. Schnell, S. Salisbury, and H. Forman, National Trends in CT Use in the Emergency Department: 1995???2007, Radiology, vol.258, issue.1, p.16473, 2011.
DOI : 10.1148/radiol.10100640

Y. Jung, D. Park, S. Hong, E. Kim, Y. Kim et al., Predictors of Urgent Findings on Abdominopelvic CT in Patients with Crohn???s Disease Presenting to the Emergency Department, Digestive Diseases and Sciences, vol.35, issue.4, p.92935, 2015.
DOI : 10.1007/s10620-014-3298-9

S. Chatu, V. Subramanian, and R. Pollok, Meta-analysis: diagnostic medical radiation exposure in inflammatory bowel disease, Alimentary Pharmacology & Therapeutics, vol.53, issue.5, p.52939, 2012.
DOI : 10.1111/j.1365-2036.2011.04975.x

K. Kroeker, S. Lam, I. Birchall, and R. Fedorak, Patients With IBD are Exposed to High Levels of Ionizing Radiation Through CT Scan Diagnostic Imaging, Journal of Clinical Gastroenterology, vol.45, issue.1, p.349, 2011.
DOI : 10.1097/MCG.0b013e3181e5d1c5

C. Kerner, K. Carey, C. Baillie, A. Mills, W. Yang et al., Clinical predictors of urgent findings on abdominopelvic CT in emergency department patients with Crohn's disease, Inflamm Bowel Dis, vol.19, issue.6, p.117985, 2013.

A. Desmond, K. O-'regan, N. Malik, S. Mcwilliams, O. Neill et al., Selection of Symptomatic Patients With Crohn's Disease for??Abdominopelvic Computed Tomography: Role of Serum C-Reactive??Protein, Canadian Association of Radiologists Journal, vol.63, issue.4, p.26774, 2012.
DOI : 10.1016/j.carj.2011.06.003

B. Varda, J. Mcnabb-baltar, A. Sood, K. Ghani, A. Kibel et al., Urolithiasis and urinary tract infection among patients with inflammatory bowel disease: a review of US emergency department visits between, Urology, vol.85, issue.4, p.76470, 2006.

L. Graff, J. Walker, and C. Bernstein, Depression and anxiety in inflammatory bowel disease: A review of comorbidity and management, Inflammatory Bowel Diseases, vol.15, issue.7, pp.1105-1123, 2009.
DOI : 10.1002/ibd.20873

A. Ananthakrishnan, V. Gainer, T. Cai, R. Perez, S. Cheng et al., Similar Risk of Depression and Anxiety Following Surgery or Hospitalization for Crohn's Disease and Ulcerative Colitis, The American Journal of Gastroenterology, vol.4, issue.4, p.594601, 2013.
DOI : 10.1038/ajg.2012.471

J. Gradus, P. Qin, A. Lincoln, M. Miller, E. Lawler et al., Inflammatory bowel disease and completed suicide in Danish adults, Inflammatory Bowel Diseases, vol.16, issue.12, p.215861, 2010.
DOI : 10.1002/ibd.21298

G. Nguyen, F. Saibil, A. Steinhart, Q. Li, and J. Tinmouth, Postoperative Health-Care Utilization in Crohn's Disease: The Impact of Specialist Care, The American Journal of Gastroenterology, vol.99, issue.10, p.15229, 2012.
DOI : 10.1146/annurev.publhealth.19.1.17

F. Casellas, G. Fontanet, N. Borruel, and J. Malagelada, The opinion of patients with inflammatory bowel disease on healthcare received, Revista Espa??ola de Enfermedades Digestivas, vol.96, issue.3, p.17484, 2004.
DOI : 10.4321/S1130-01082004000300003

J. Wasson, C. Gaudette, F. Whaley, A. Sauvigne, P. Baribeau et al., Telephone Care as a Substitute for Routine Clinic Follow-up, JAMA: The Journal of the American Medical Association, vol.267, issue.13, p.178893, 1992.
DOI : 10.1001/jama.1992.03480130104033

C. Sack, V. Phan, R. Grafton, G. Holtmann, D. Van-langenberg et al., A chronic care model significantly decreases costs and healthcare utilisation in patients with inflammatory bowel disease, Journal of Crohn's and Colitis, vol.6, issue.3, p.30210, 2012.
DOI : 10.1016/j.crohns.2011.08.019

C. Ramos-rivers, M. Regueiro, E. Vargas, E. Szigethy, R. Schoen et al., Association Between Telephone Activity and Features of??Patients??With Inflammatory Bowel Disease, Clinical Gastroenterology and Hepatology, vol.12, issue.6, p.9869, 2014.
DOI : 10.1016/j.cgh.2013.11.015

M. Rejler, A. Spångéus, J. Tholstrup, and B. Andersson-gäre, Improved Population-based Care, Quality Management in Health Care, vol.16, issue.1, p.3850, 2007.
DOI : 10.1097/00019514-200701000-00006

P. Rudd, N. Miller, J. Kaufman, H. Kraemer, A. Bandura et al., Nurse management for hypertension. A systems approach, Am J Hypertens, vol.17, issue.10, pp.921-928, 2004.

J. Piette, M. Weinberger, and S. Mcphee, The Effect of Automated Calls With Telephone Nurse Follow-Up on Patient-Centered Outcomes of Diabetes Care, Medical Care, vol.38, issue.2, p.21830, 2000.
DOI : 10.1097/00005650-200002000-00011

A. Ananthakrishnan, E. Mcginley, D. Binion, and K. Saeian, Physician density and hospitalization for inflammatory bowel disease, Inflammatory Bowel Diseases, vol.17, issue.2, p.6338, 2011.
DOI : 10.1002/ibd.21357